Reproductive preservation for treatment of stage IA endometrial cancer in a young woman: Hysteroscopic resection

International Journal of Gynecological Cancer

Volumn 15, Issue 5, 2005, Pages 974-978

  Mazzon, I ^a   Corrado, G ^b   Morricone, D ^a   Scambia, Giovanni ^b,c  

^a Endoscopic Gynecologic Unit   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

Conservative treatment; Endometrial cancer; Hormone therapy; Hysteroscopy

Indexed keywords

HORMONE RECEPTOR; MEGESTROL ACETATE;

ADULT; ANAMNESIS; ARTICLE; CANCER STAGING; CASE REPORT; CESAREAN SECTION; CLINICAL FEATURE; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; GESTATIONAL AGE; HORMONAL THERAPY; HUMAN; HYSTERECTOMY; INFERTILITY THERAPY; LEIOMYOMATOSIS; LYMPH NODE; MYOMECTOMY; PRIORITY JOURNAL; PROGNOSIS; SALPINGOOOPHORECTOMY; TRANSVAGINAL ECHOGRAPHY; TUMOR VOLUME;

ADULT; CESAREAN SECTION; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTEROSCOPY; INFANT, NEWBORN; MALE; NEOPLASM STAGING; PARTURITION; PREGNANCY; REPRODUCTIVE MEDICINE;

EID: 26844524634     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2005.00162.x     Document Type: Article

References (14)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics 2001. CA Cancer J Clin 2001;51:15-36.
2. Wolfson AH, Sightler SE, Markoe AM et al. The progostic significance of surgical staging for carcinoma of the endometrium. Gynecol Oncol 1992;45:142-6.
3. Benedet JL, Bender H, Jones H 3rd, Ngan HY, Pecorelli S. Staging classifications and clinical practice guidelines of gynecologic cancers. Int J Gynecol Obstet 2000;70: 207-312.
4. International Federation of Obstetrics and Gynecology annual report on the results of treatment in gynecologic cancer. Int J Gynecol Obstet 2003;83(suppl 1):1-129.
5. Kurman RJ, Norris HJ. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well differentiated carcinoma. Cancer 1982;49:2547-59.
6. Irvin WP, Rice LW, Berkowitz RS. Advances in the management of endometrial adenocarcinoma. J Reprod Med 2002;47:173-90.
7. Morrow CP, Bundy BN, Kurman RJ et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of endometrium: a gynecologic oncology group study. Gynecol Oncol 1991;40:55-65.
8. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer (a GOG study). Cancer 1987;60:2035-41.
9. Gotlieb WH, Beiner ME, Shalmon B et al. Outcome of fertility sparing treatment with progestins in young patients with endometrial cancer. Obstet Gynecol 2003;102:718-25.
10. Kung FT, Chen WJ, Chou HH, Ko SF, Chang SY. Conservative management of early endometrial adenocarcinoma with repeat curettage and hormone therapy under assistance of hysteroscopy and laparoscopy. Hum Reprod 1997;12:1649-53.
11. Keith WK, Cheung TH, Yim SF, Chung TK. Hysteroscopic dissemination of endometrial carcinoma using carbon dioxide and normal saline: a retrospective study. Gynecol Oncol 2002;84:394-8.
12. Gu M, Shi W, Huang J, Barakat RR, Thaler HT, Saigo PE et al. Association between initial diagnostic procedure and hysteroscopy and abnormal peritoneal washings in patients with endometrial carcinoma. Cancer 2000;90:143-7.
13. Sardi J, Anchezar Henry JP, Paniceres G, Gomez Rueda N, Vighi S. Primary hormonal treatment for early endometrial carcinoma. Eur J Gynaecol Oncol 1998;19:565-8.
14. Manfredi R, Mirk P, Maresca G et al. Loco-regional staging of endometrial carcinoma: role of MR imaging in surgical staging. Radiology 2004;231:372-8.